NEW YORK (GenomeWeb) – Luminex said this week that it has reached an agreement whereby Laboratory Corporation of America is extending its commitment to the Luminex Cystic Fibrosis product line through Dec. 31, 2019. This indicates that LabCorp would maintain at least its current volume of CF testing with Luminex through calendar year 2019.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.